Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Zydus Lifesciences Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	532321
ISIN Demat	INE010B01027
Book Value	210.59

NSE Code	ZYDUSLIFE
Dividend Yield %	1.12
Market Cap	988222.40

P/E	17.11
EPS	57.39
Face Value	1


	BSE		NSE

26-Jun-2025

Last Price	982.10
Net Change	7.15
% Change	0.73%
Prev.Close	974.95
Open	975.40
High	983.75
Low	968.60
Volume	74922

Last Price	981.95
Net Change	7.2
% Change	0.74%
Prev.Close	974.75
Open	979.20
High	983.50
Low	967.85
Volume	876152

Value	73493891
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	983.75
52-Week High	1323.90
52-Week Low	797.05

Value	858128094.95
Best Buy	0.00
Best Sell	981.95
Best Quantity	0
Sell Quantity	70
Today's Range	983.50
52-Week High	1324.30
52-Week Low	795.00

Open Price	974.85
High Price	985.90
Low Price	968.00
Last Price	984.00
Prev Close	973.35
Change	10.65
% Change	1.09 %

Average Price	978.19
Underlying Value	981.95
Number of contracts traded	1705
Turnover in Rs. Lakhs	15010
Open Interest	802800.00
Change in O I	-94500.00
% Change in O I	-10.53 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	70
Price	981.95

Best Bid

Best Offer

Quantity	900
Price	979.45

Quantity	7200
Price	984

Holding Details

Latest Corporate Events

Bonus

1 : 2

05-Apr-10

Book Closure

30-Jul-21

06-Aug-21

Dividend

1100 %

25-Jul-25

Company News

19-06-2025

Announcement under Regul...

19-06-2025

USFDA concludes GMP follo...

19-06-2025

Zydus Lifesciences infor...

12-06-2025

Zydus Lifesciences gets E...

12-06-2025

Zydus Lifesciences gains ...

10-06-2025

Zydus Lifesciences gets E...

04-06-2025

Zydus Lifesciences’ arm e...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.